A method for the synthesis of n-methyl-5-methoxytryptamine
By using a synthesis method based on zinc chloride and quaternary ammonium salt catalysts, the safety hazards and high costs of N-methyl-5-methoxytryptamine synthesis in existing technologies have been solved, enabling industrial production with high purity and high yield.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- HEBEI WEIDAKANG BIOTECHNOLOGY CO LTD
- Filing Date
- 2023-10-10
- Publication Date
- 2026-07-21
AI Technical Summary
The existing synthesis process for N-methyl-5-methoxytryptamine has problems such as significant safety hazards, harsh reaction conditions, high cost, low yield, and low purity, making it difficult to achieve industrial-scale production.
Using 5-methoxytryptamine as a raw material, under nitrogen atmosphere, with zinc chloride and quaternary ammonium salt catalysts as catalysts and sodium triacetoxyborohydride as a reducing agent, N-methyl-5-methoxytryptamine was synthesized by reacting with formaldehyde. By controlling the reaction temperature and pH value, the monomethylation selectivity and the forward reaction equilibrium were improved.
The synthesis of N-methyl-5-methoxytryptamine was achieved with simple process, mild conditions, high yield, high purity and low cost. The product purity reached more than 99.4%, the impurity content was less than 0.1%, and the yield reached more than 98.5%.
Smart Images

Figure BDA0004486135130000021 
Figure BDA0004486135130000081